The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients

Cancer Cell

Volumn 1, Issue 2, 2002, Pages 129-132

  Elledge, Stephen J ^a   Amon, Angelika ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; DNA;

ALLELE; BREAST CARCINOMA; CARCINOGENESIS; DNA DAMAGE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; HETEROZYGOSITY; HUMAN; LETTER; NONHUMAN; ONCOGENE; OVARY CARCINOMA; PREDICTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; BREAST TUMOR; CELL DIVISION; CELL SURVIVAL; FEMALE; GENETICS; HETEROZYGOTE; METABOLISM; MUTATION; OVARY TUMOR; TUMOR SUPPRESSOR GENE;

BRCA1 PROTEIN; BREAST NEOPLASMS; CELL DIVISION; CELL SURVIVAL; FEMALE; GENES, BRCA1; HETEROZYGOTE; HUMANS; MODELS, BIOLOGICAL; MUTATION; ORGAN SPECIFICITY; OVARIAN NEOPLASMS;

EID: 0036491931     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00041-7     Document Type: Letter

References (20)

1. Blackwood, M.A., and Weber, B.L. (1998). BRCA1 and BRCA2: from molecular genetics to clinical medicine. J. Clin. Oncol. 16, 1969-1977.
2. Brown, E.J., and Baltimore, D. (2000). ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14, 397-402.
3. Cressman, V.L., Backlund, D.C., Avrutskaya, A.V., Leadon, S.A., Godfrey, V., and Koller, B.H. (1999). Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol. Cell Biol. 19, 7061-7075.
4. Easton, D.F., Ford, D., and Bishop, D.T. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 56, 265-271.
5. Fan, S., Ma, Y.X., Wang, C., Yuan, R.Q., Meng, Q., Wang, J.A., Erdos, M., Goldberg, I.D., Webb, P., Kushner, P.J., et al. (2001). Role of direct interaction in BRCA1 Inhibition of estrogen receptor activity. Oncogene 20, 77-87.
6. Gompel, A., Somai, S., Chaouat, M., Kazem, A., Kloosterboer, H.J., Beusman, I., Forgez, P., Mimoun, M., and Rostene, W. (2000). Hormonal regulation of apoptosis in breast cells and tissues. Steroids 65, 593-598.
7. Gowen, L.C., Johnson, B.L., Latour, A.M., Sulik, K.K., and Koller, B.H. (1996). Brcal deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12, 191-194.
8. Hakem, R., de la Pompa, J.L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996). The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009-1023.
9. Kousteni, S., Bellido, T., Plotkin, L.I., O'Brien, C.A., Bodenner, D.L., Han, L., Han, K., DiGregorio, G.B., Katzenellenbogen, J.A., Katzenellenbogen, B.S., et al. (2001). Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104, 719-730.
10. Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., Donehower, L.A., and Elledge, S.J. (2000). Chk1 is an essential kinase that is regulated by Atrand required for the G2/M DNA damage checkpoint. Genes Dev. 14, 1448-1459.
11. Ludwig, T., Chapman, D.L., Papaioannou, V.E., and Efstratiadis, A. (1997). Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11, 1226-1241.
12. Ludwig, T., Fisher, P., Ganesan, S., and Efstratiadis, A. (2001). Tumorigenesis in mice carrying a truncating Brca1 mutation. Genes Dev. 15, 1188-1193.
13. Moynahan, M.E., Chiu, J.W., Koller, B.H., and Jasin, M. (1999). Brca1 controls homology-directed DNA repair. Mol. Cell 4, 511-518.
14. Neuhausen, S.L., and Ostrander, E.A. (1997). Mutation testing of early-onset breast cancer genes BRCA1 and BRCA2. Genet. Test. 1, 75-83.
15. Rosen, E.M., Fan, S., and Goldberg, I.D. (2001). BRCA1 and prostate cancer. Cancer Invest. 19, 396-412.
16. Rutanen, E.M. (1998). Insulin-like growth factors in endometrial function. Gynecol. Endocrinol. 12, 399-406.
17. Sassoon, D. (1999). Wnt genes and endocrine disruption of the female reproductive tract: a genetic approach. Mol. Cell. Endocrinol. 158, 1-5.
18. Scully, R., and Livingston, D.M. (2000). In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429-432.
19. Welcsh, P.L., Schubert, E.L., and King, M.C. (1998). Inherited breast cancer: an emerging picture. Clin. Genet. 54, 447-458.
20. Xu, X., Qiao, W., Linke, S.P., Cao, L., Li, W.M., Furth, P.A., Harris, C.C., and Deng, C.X. (2001). Genetic interactions between tumor suppressors Brcal and p53 in apoptosis, cell cycle and tumorigenesis. Nat. Genet. 28, 266-271.